These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 9536559)
1. Postmenopausal HRT--a role for a safe antioestrogen. Jackson I; Steinberg M; Orton TC Int J Clin Pract; 1998; 52(1):5-6. PubMed ID: 9536559 [No Abstract] [Full Text] [Related]
2. Postmenopausal HRT--a role for a safe antioestrogen. Williams GM Int J Clin Pract; 1998; 52(1):5. PubMed ID: 9536558 [No Abstract] [Full Text] [Related]
3. MR appearance of endometrial carcinoma and mucinous cystadenoma in a postmenopausal patient treated with tamoxifen for breast cancer. Joja I; Asakawa T; Ando Y; Shiraiwa M; Shibutani O; Akaki S; Kuroda M; Mizutani Y; Kudo T; Hiraki Y Radiat Med; 1998; 16(4):315-9. PubMed ID: 9814431 [TBL] [Abstract][Full Text] [Related]
4. [Tamoxifen and endometrial cancer]. Salamanca-Gómez F Gac Med Mex; 2006; 142(2):171-2. PubMed ID: 16711554 [No Abstract] [Full Text] [Related]
8. Endometrial carcinoma can develop in patients on tamoxifen therapy. Omar SZ; Sivanesaratnam V Med J Malaysia; 1999 Jun; 54(2):280-2. PubMed ID: 10972045 [No Abstract] [Full Text] [Related]
9. Tamoxifen ruling in California. Mack T Science; 1995 Nov; 270(5239):1102-3. PubMed ID: 7502022 [No Abstract] [Full Text] [Related]
10. Endometrial polyps: a comparison study of patients receiving tamoxifen with two control groups. Schlesinger C; Kamoi S; Ascher SM; Kendell M; Lage JM; Silverberg SG Int J Gynecol Pathol; 1998 Oct; 17(4):302-11. PubMed ID: 9785130 [TBL] [Abstract][Full Text] [Related]
11. Endometrial polyps in pre-and postmenopausal women: factors associated with malignancy. Cohen I Maturitas; 2008 Jan; 59(1):99-100. PubMed ID: 18162338 [No Abstract] [Full Text] [Related]
13. Endometrial cancers from tamoxifen are not more aggressive. Ziegler J J Natl Cancer Inst; 1996 Aug; 88(16):1101. PubMed ID: 8757186 [No Abstract] [Full Text] [Related]
14. Breast cancer chemoprevention: risk-benefit effects of the antioestrogen tamoxifen. Brown K Expert Opin Drug Saf; 2002 Sep; 1(3):253-67. PubMed ID: 12904141 [TBL] [Abstract][Full Text] [Related]
15. Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients. Cohen I; Bernheim J; Azaria R; Tepper R; Sharony R; Beyth Y Gynecol Oncol; 1999 Oct; 75(1):136-41. PubMed ID: 10502440 [TBL] [Abstract][Full Text] [Related]
16. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report. Sinawat S; Chiyabutra T; Kleabkaew P J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963 [TBL] [Abstract][Full Text] [Related]
17. [The effects of tamoxifen on the female genital tract]. Mourits MJ; van der Zee AG; Willemse PH; Hollema H; de Vries EG Ned Tijdschr Geneeskd; 2003 Nov; 147(47):2315-20. PubMed ID: 14669536 [TBL] [Abstract][Full Text] [Related]
18. The effect of clodronate and antioestrogens on bone loss associated with oestrogen withdrawal in postmenopausal women with breast cancer. Saarto T; Vehmanen L; Elomaa I; Välimäki M; Mäkelä P; Blomqvist C Br J Cancer; 2001 Apr; 84(8):1047-51. PubMed ID: 11308252 [TBL] [Abstract][Full Text] [Related]
19. Tamoxifen in cancer therapy: minireview. Novotny L; Rauko P; Vachálková A; Peterson-Biggs M Neoplasma; 2000; 47(1):3-7. PubMed ID: 10870680 [TBL] [Abstract][Full Text] [Related]
20. Adjuvant tamoxifen versus tamoxifen plus CMF in the treatment of early breast cancer in Greece. Fifteen-year results of a randomised prospective trial and the potential risks of the antioestrogen. Vorgias G; Koukouras D; Tzoracoeleftherakis E; Paleogianni V; Androulakis J Anticancer Res; 2000; 20(5C):3849-54. PubMed ID: 11268466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]